Denali Advisors LLC Has $2.17 Million Stock Position in Crescent Capital BDC, Inc. $CCAP

Denali Advisors LLC decreased its stake in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP) by 13.9% during the 2nd quarter, Holdings Channel reports. The firm owned 153,691 shares of the company’s stock after selling 24,894 shares during the period. Denali Advisors LLC’s holdings in Crescent Capital BDC were worth $2,167,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the stock. Kovitz Investment Group Partners LLC increased its holdings in shares of Crescent Capital BDC by 14.4% during the 1st quarter. Kovitz Investment Group Partners LLC now owns 202,873 shares of the company’s stock worth $3,473,000 after acquiring an additional 25,528 shares during the last quarter. Invesco Ltd. increased its holdings in shares of Crescent Capital BDC by 59.7% during the 1st quarter. Invesco Ltd. now owns 29,197 shares of the company’s stock worth $500,000 after acquiring an additional 10,911 shares during the last quarter. BI Asset Management Fondsmaeglerselskab A S increased its holdings in shares of Crescent Capital BDC by 39.5% during the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 63,893 shares of the company’s stock worth $1,094,000 after acquiring an additional 18,078 shares during the last quarter. HighTower Advisors LLC increased its holdings in shares of Crescent Capital BDC by 0.5% during the 1st quarter. HighTower Advisors LLC now owns 137,366 shares of the company’s stock worth $2,352,000 after acquiring an additional 702 shares during the last quarter. Finally, Mackenzie Financial Corp acquired a new position in shares of Crescent Capital BDC during the 1st quarter worth approximately $804,000. Institutional investors and hedge funds own 49.46% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the company. LADENBURG THALM/SH SH raised Crescent Capital BDC to a “strong-buy” rating in a report on Friday, August 15th. Zacks Research downgraded Crescent Capital BDC from a “hold” rating to a “strong sell” rating in a research note on Wednesday, October 15th. Wall Street Zen raised Crescent Capital BDC from a “sell” rating to a “hold” rating in a report on Friday, June 27th. Finally, Keefe, Bruyette & Woods raised Crescent Capital BDC from a “hold” rating to a “moderate buy” rating in a report on Tuesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Crescent Capital BDC presently has an average rating of “Moderate Buy” and a consensus price target of $16.33.

Crescent Capital BDC Stock Up 1.5%

Shares of NASDAQ CCAP opened at $14.07 on Wednesday. The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 1.22. The stock’s fifty day moving average price is $14.98 and its two-hundred day moving average price is $14.97. Crescent Capital BDC, Inc. has a one year low of $13.31 and a one year high of $20.19.

Crescent Capital BDC (NASDAQ:CCAP) last issued its quarterly earnings data on Wednesday, August 13th. The company reported $0.46 EPS for the quarter, meeting analysts’ consensus estimates of $0.46. The firm had revenue of $42.99 million for the quarter, compared to analyst estimates of $42.52 million. Crescent Capital BDC had a return on equity of 10.55% and a net margin of 24.12%. On average, sell-side analysts anticipate that Crescent Capital BDC, Inc. will post 2.09 earnings per share for the current year.

Crescent Capital BDC Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Tuesday, September 30th were given a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a dividend yield of 11.9%. The ex-dividend date was Tuesday, September 30th. Crescent Capital BDC’s dividend payout ratio is presently 140.00%.

Insider Buying and Selling at Crescent Capital BDC

In related news, Director Raymond Barrios bought 3,245 shares of the business’s stock in a transaction dated Monday, August 25th. The stock was purchased at an average cost of $15.63 per share, for a total transaction of $50,719.35. Following the transaction, the director owned 19,177 shares in the company, valued at $299,736.51. The trade was a 20.37% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.14% of the company’s stock.

Crescent Capital BDC Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.